
äžé¢å§å¡äŒãFDAãCDCãNIHé¢ä¿è ãCOVIDãã³ãããã¯ãžã®å¯Ÿå¿ã§å°å
å èšäºã¯ãã¡ããã/Click here to read the original article.
COVID-19ãã³ãããã¯ããåŠãã æèšã«é¢ããå é±ã®è°äŒå ¬èŽäŒã®ãã€ã©ã€ãã¯ãæ¿åºã«ãã£ãŠçŸ©åã¥ããããããã¯ããŠã³ãšãã¹ã¯ããããŠå ¬è¡è¡çæ©é¢ã«ããCOVID-19ã¯ã¯ãã³ã®ç£ç£ãšé©åãªå®å šæ§ãã¹ãã®æ¬ åŠã«å¯Ÿããæ¹å€ã§ãã£ãã
COVID-19ãã³ãããã¯ããåŠãã æèšã«é¢ããå é±ã®è°äŒå ¬èŽäŒã®ãã€ã©ã€ãã¯ãæ¿åºã«ãã£ãŠçŸ©åä»ããããããã¯ããŠã³ãšãã¹ã¯ããããŠå ¬è¡è¡çæ©é¢ã«ããCOVID-19ã¯ã¯ãã³ã®ç£ç£ãšé©åãªå®å šæ§ãã¹ãã®æ¬ åŠã«å¯Ÿããæ¹å€ã§ãã£ãã
å ¬èŽäŒã§ã¯ãŸããã¢ã³ãœããŒã»ãã¡ãŠãå士ã®å åŽè¿ããããã»Mã»ã¢ãŒã³ãºå士ããCOVID-19ã®èµ·æºã«é¢é£ããæ å ±å ¬éæ³ïŒFOIAïŒã®èŠè«ãéããããã«å人çãªé»åã¡ãŒã«ã¢ã«ãŠã³ãã䜿çšããããšã§åçºãããããçŸåšãåœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æïŒNIAIDïŒã«å€åããŠããããšãæããã«ãªã£ãã
ããäžé¢è°å¡ã¯å ¬èŽäŒãå©çšããŠãããã«ãã»Jã»ãã©ã³ã次æå€§çµ±é ãç±³åœä¿å¥ç€ŸäŒçŠç¥çïŒHHSïŒã®é·å®ã«æåãããããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢ãæ»æããã±ããã£ããã®åœ¹å²ãæ ãããšã ãæ¥ãã¹ãããš ããšåŒãã ã
11æ14æ¥ãç±³äžé¢ã³ãããŠã€ã«ã¹å¯Ÿçç¹å¥å°å§å¡äŒã§èšŒèšããã®ã¯ä»¥äžã®éãïŒ
ç±³åœé£åå»è¬åå±ïŒFDAïŒã®ããŒãã»ã¡ãã£ã«ã«ã»ãªãã£ãµãŒããã©ãªãŒã»ããŒã¹ãã³å士ã
ç±³åœåœç«è¡çç ç©¶æïŒNIHïŒäž»åžå¯æé·ããŒã¬ã³ã¹ã»ã¿ããã¯å士ïŒDDSïŒã
ãã³ãªãŒã»ãŠã©ã«ã±å士ãçŸç 察çäºé²ã»ã³ã¿ãŒïŒCDCïŒæºåã»å¯Ÿå¿å®€é·ã
å ¬èŽäŒãåèŽããChildren's Health DefenseïŒCHDïŒã®äžçŽç ç©¶å¡ã§ããã«ãŒã«ã»ãžã£ããããŠã¹ããŒå士ã¯ãããã®å°å§å¡äŒããåŠãã æèšã®ã²ãšã€ã¯ãç§ãã¡ããŸã ç¥ããªãã£ãããã§ã¯ãããŸããããHHSã«ã¯ã·ã¹ãã äžã®æ¬ é¥ããããšããããšã§ãã[ã·ã¹ãã çæ¬ é¥ã¯ãç®ã«èŠããå°æ°ã®æªè³ªãªè¡çºè ã«å¯Ÿããæ²çœ°çæªçœ®ã®ææ¡ãã¯ããã«è¶ ãããã®ã§ããã»ã»ã»ã·ã¹ãã çæ¬ é¥ãæ¯æ£ããã«ã¯ãã·ã¹ãã å šäœã®å€é©ãå¿ èŠã§ããã
HHSã¯FDAãCDCãNIHãç£ç£ããŠããã
ãã¡ãŠãããåãã€ããå€ãã®äººã ãæ»ãã ã
ãããŒãã»ã¬ã«ã·ã¢è°å¡ïŒæ°äž»å ãã«ãªãã©ã«ãã¢å·éžåºïŒã¯å ¬èŽäŒã§ã±ããã£ã«å¯Ÿããæ»æãéå§ããããã³ãããã¯ã«ãã£ãŠ130äžäººã®ã¢ã¡ãªã«äººãæ»äº¡ããããšãåŒãåãã«åºãããçŸä»£ã«ãããŠå¯äžæå€§ã®äººåœæå€±ãã§ãããšããŠãã¬ã«ã·ã¢è°å¡ã¯ã±ããã£ã®æåããéåžžã«ãéåžžã«æžå¿µããŠããããšè¿°ã¹ãã圌ã¯èšã£ãïŒ
ãç§åŠçãå»åŠçãªè³æ Œããªããäœå幎ãã®éãã¯ã¯ãã³ãèªéçãåŒãèµ·ãããšåœã£ãŠäž»åŒµããççŽã«èšã£ãŠãç§åŠãå»åŠã«ã€ããŠãšãã§ããªãçºèšãããŠãã人ç©ãæåããããšãæ€èšããŠããããã®ãããªäººç©ãNIHã®æ ¹å¹¹ãæºããããããªããšããããšã¯ãæ¥ãã¹ãããšã ãšæããŸãã
ãRFKãžã¥ãã¢ãã¯ã¯ãã³åŠå®è«è ã§ãããã¢ã¡ãªã«åœæ°ã«å€å€§ãªå®³ããããããã®ã«ãä¿å¥ã®è²¬ä»»è ã«ä»»åœãããå¯èœæ§ãããããšããåœãšããŠéåžžã«æžå¿µãã¹ãã§ããã
ããŒãžã§ãªãŒã»ãã€ã©ãŒã»ã°ãªãŒã³äžé¢è°å¡ïŒå ±åå ïŒã¯ã¬ã«ã·ã¢æ°ã«å¯Ÿãããã€ãã³æ¿æš©ãšå ¬è¡è¡çæ©é¢ã ãã¢ã¡ãªã«åœæ°ã®å¥åº·ãäžçã®å¥åº·ããããŠåäŸãã¡ã®å¥åº·ã«å¯ŸããæŠäº ãã仿ããŠãããšéé£ããã
ã°ãªãŒã³ã¯5åéã®å£°æã®äžã§ãCOVID-19ãäœãåºããã®ã¯ç±³åœæ¿åºã§ãããããã«ç¶ãäžåœã®æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æããã® ç 究宀æµåºã«ã責任ããããšè¿°ã¹ãã圌女ã¯èšã£ãïŒ
ãæ¿åºãšãã®åŒ·åãªæ©é¢ã¯ãCOVID-19ã®ããã«äžçã«æŸããããŠã€ã«ã¹ãäœãããã«ãã¢ã¡ãªã«åœæ°ã®çšŒãã çšéã䜿ã£ãŠã¯ãªããªãã
ãCOVID-19ã¯äžåœã®ãã€ãªã©ãã§æ©èœç²åŸã䜿ã£ãŠè³éã調éãããããŠåãã€ããããã¡ãŠãå士ã¯ã¢ã¡ãªã«åœæ°ã«åãã€ããæš©åãšå°äœãšåœ¹å²ãä¹±çšããã圌ã¯åãã€ããå€ãã®äººã ã亡ããªã£ãã®ã§ããã
ã°ãªãŒã³æ°ã¯ãŸããCOVID-19ã®ããã¯ããŠã³ãåŠæ ¡ééãåäŸãã¡ã®ãã¹ã¯ãªã©ã®å¶éãæ¹å€ããã
ãåã©ããã¡ã¯COVID-19ã«ãã£ãŠå ¥é¢ãããæ»äº¡ãããããå±éºã¯ãªãã£ãã®ã«ãåã©ããã¡ã¯ãããªãæ¹ã®æ©é¢ãå€ãã®éœåžãå·ãæ¿åºã®è²¬ä»»è ã«ããäžæ£è¡çºãæš©åã®ä¹±çšã®ææªã®ç ç²è ã®äžäººãšãªã£ãããŸã£ããæãããããšã§ãããšã°ãªãŒã³æ°ã¯èªã£ãã
ã°ãªãŒã³æ°ã¯ããããã®æ¿çãã¢ã¡ãªã«ã«ãããå ¬è¡è¡çã®å±æ©ãå¢å€§ãããäžå ãšãªã£ããšèªã£ãã
ãèªæ®ºè ã¯é廿é«ãèšé²ããæãæ²ããããšã¯ãåäŸãã¡ã®éã§èšé²çãªèªæ®ºçã èŠãããããšãšããã€ãŠãªãã»ã©ã¢ã¡ãªã«äººã«ç²Ÿç¥è¡çäžã®å±æ©ãæŸãããããšã§ãããšã°ãªãŒã³æ°ã¯èªã£ãã
ã°ãªãŒã³ã«ããã°ããããã®æ¿çãæ¹å€ãã人ã ã¯æ€é²ããããšããã圌女ã¯èšã£ãïŒ
ãåŠæ ¡ã¯ééããã人ã ã®ä»äºã¯åæ¢ãããéçšã¯æã¡åãããäžå°äŒæ¥ã¯ééãããã誰ããç¥ã£ãŠããçæŽ»ãééãããã®ã§ãããã®çµæã人ã ã®æ²æ³ä¿®æ£ç¬¬1æ¡ã®æš©å©ãèšè«ã®èªç±ãä¿¡æã®èªç±ã䟵害ãããã
ã€ãã«ã¡ã¯ãã³ãäºéãã¿ãã³Dã䜿ã£ãæ²»çæ³ãçºè¡šããå»åž«ãããããã銬ã®ããŒã¹ãããšã¬ããã«ã貌ããããã®å»åž«ãã¡ã¯æ»æãããæ¹å€ãããé°è¬è«è ãšåŒã°ããã
圌ãã¯ã¢ã¡ãªã«åœæ°ã«äœãé ããåãã€ããŠããã®ãïŒ
ã°ãªãŒã³ã¯ãŸããCOVID-19ã¯ã¯ãã³ããããŠå ¬è¡è¡çæ©é¢ã«ããã¯ã¯ãã³ã®ç£ç£ã«ã€ããŠãæ¹å€ããã圌女ã¯èšã£ãïŒ
ãFDAã¯ãã¯ã¯ãã³ãå¹ãããæ»ã«è³ãå¯äœçšãããããšã瀺ã詊éšãããŒã¿ãæãããæ¥ãã®æ¿èªããã»ã¹ã«ãã£ãŠå®éšçãªã¯ã¯ãã³ãæ¿èªãããFDAã¯ããã75幎éå°å°ããããšããã
ãFDAã¯ã¢ã¡ãªã«åœæ°ã«äœãé ããåãã€ããŠããã®ãïŒç§ãã¡ã¯ãããç¥ã£ãŠããã...VAERSïŒã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ïŒã§ã¯ã¯ãã³ã®æå·ãæ»äº¡ãå ±åãã人ã ã¯ç¡èŠããããå²ç¬ããããé°è¬è«è ãšåŒã°ããèªåãå®¶æã«èµ·ãã£ãæãããåºæ¥äºã«ã€ããŠèªãããšãããšããœãŒã·ã£ã«ã¡ãã£ã¢äžã§ãã£ã³ã»ã«ãããã
ããªã¢ãããã»ãã©ãŒïŒããŒã¯ã¹è°å¡ïŒã¢ã€ãªã¯å·éžåºïŒã¯ãè¥ãç·æ§ã®å¿ççã«é¢ããCOVID-19ã¯ã¯ãã³é¢é£ã®å®å šã·ã°ãã«ã«ã€ããŠãŠã©ã«ã±ã«è³ªåããã圌女ã¯ãCDCã ãèµ·ããããæå®³ãªçµæã«é¢ããè©³çŽ°ãªæ å ±ã®æ¬ åŠ ãã«ãã£ãŠããã®ãªã¹ã¯ã ãè»œèŠ ãããã®ã§ã¯ãªãããšãŠã©ãŒã¯ã«è³ªåããã
ãCOVIDã¯ã¯ãã³ã¯ãæŽå²äžãã£ãšã峿 Œãªå®å šæ§ç£èŠãåããŠããŸãããšãŠã©ãŒã¯ã¯èšã£ãã
ãã¯ã¯ãã³ã¯ä¿¡ããããªãã»ã©å¹æçã§ãããæåã®é²åŸ¡çã§ãããæã ã¯ãŸããCDCãäžè¬åžæ°ã®ããã«æšå¥šãè¡ãããå ¬è¡è¡çæ©é¢ããã®æšå¥šãè§£éããããã«ã¯ãå»çè ãšæ£è ã®é¢ä¿ãéåžžã«éèŠã§ãããšèããŠããã
ãŠã©ã«ã±ã¯ãŸããå ¬è¡è¡çæ©é¢ãã¯ã¯ãã³ã®ãªã¹ã¯ãäžè¬åžæ°ã«ãã£ãšããŸãäŒããããšãã§ããã¯ãã ãšãèªããã圌ã¯èšãïŒ
ããã£ãããã®çš®ã®æ å ±ãåŸãããã°ãç§ãã¡ã¯ç§åŠçãªåºçç©ãå«ãããŸããŸãªæ¹æ³ã§ãããæŒãåºãããšããŸãã
ãããããç¹°ãè¿ãã«ãªããŸãããæãåœã«ã¯æ§ã ãªå°å瀟äŒããããç§ãã¡ã¯ãã®ãããªå°å瀟äŒã«åããããŠãã¯ã¯ãã³ã«é¢ããŠã©ã®ãããªåé¡ãããã®ãã«ã€ããŠè©±ãããããããã£ãšåªåããå¿ èŠããããšæããŸãã
ããŒã¹ãã³ã¯ãFDAã¯ã¯ã¯ãã³ã®å®å šæ§ãè©äŸ¡ããéã補è¬äŒç€Ÿã®éèŠãªããŒã¿ã ãã«é Œã£ãŠããããã§ã¯ãªããšè¿°ã¹ãããæã ã¯ç¬èªã®åæãè¡ã£ãŠããŸããäžãããããã®ãéµåã¿ã«ããã ãã§ã¯ãããŸãããFDAã®å°éå®¶ãã¡ã¯èªãããŒã¿ã調ã¹ãŸãã
ãCHDã®æé«ç§åŠè²¬ä»»è ã§ãããã©ã€ã¢ã³ã»ããã«ãŒã¯èšãããFDAã¯æ±ºããŠç¬èªã®åæãªã©ããŸãããFDAã¯ã補è¬äŒç€ŸãFDAã®ç·äºç®ã®50ïŒ ãæ åºããFastTrackããã°ã©ã ã«ãã£ãŠè²·åãããŠããã ãã§ãªããå質ãä¿¡ææ§ãã»ãšãã©åãããªã倧æè£œè¬äŒç€Ÿã®ããŒã¿ã ãã«é Œã£ãŠããã®ã§ããã
FDAã ãç¬èªã®åæ ããããŠããã«ããããããããã¡ã€ã¶ãŒã»ãã€ãªã»ããã¯ç€Ÿã«éåžžã«å±éºãªSV40ããã¢ãŒã¿ãŒãã¯ã¯ãã³è£œé ã®ãã©ã¹ããã«å¿ã³èŸŒãŸããŠããã®ã¯çŽåŸã§ããªããããã¯FDAãHHSã®ä»ã®æ©é¢ã«ãã£ãŠçºèŠãããã®ã§ã¯ãªããç¬ç«ç ç©¶è ã®ã±ãã³ã»ããã«ãŒãã³ã«ãã£ãŠãµã€ããããžã§ã¯ããšããŠçºèŠãããã®ã§ããã
ãã¡ãã¯ãè°äŒã«åãã€ããããéçšã¯ç¶ç¶
ãšã. ãžã§ãŒã ãºã»ã³ããŒè°å¡ïŒå ±åå ïŒã¯ãNIAIDæé·å®€ã®äžçŽç§åŠé¡§åã§ãããNIAIDã§25幎ã®ããã©ã³ã§ããã¢ãŒã³ãºã«å¯ŸããHHSã®èª¿æ»ã«ã€ããŠãã¿ããã¯ã«è³ªåããã
æšå¹Žãè°äŒã®èª¿æ»ã«ãããã¢ãŒã³ãºã¯å人ã®é»åã¡ãŒã«ã¢ãã¬ã¹ã䜿çšããæ¿åºã®é»åã¡ãŒã«ã¢ã«ãŠã³ãããã¡ãã»ãŒãžãåé€ããããšã«ãããæ å ±å ¬éè«æ±ãã¡ãã£ã¢ã®ç£èŠããéããããšããŠããããšãæããã«ãªã£ãããããã®ã¡ãã»ãŒãžã¯ãCOVID-19ã®èµ·æºãšç 究宀æµåºèª¬ã«é¢ãããã®ã§ãã£ãã
ã³ããŒæ°ã®è³ªåã«å¯ŸããŠã¿ããã¯æ°ã¯ãã¢ãŒã³ãºã¯NIAIDã® ããŸã è·å¡ ãã§ããããHHS㯠ããã¹ãŠã®ã±ãŒã¹ã§å¿ èŠãªæªçœ®ããšã£ãŠãã ããšè¿°ã¹ãã
ã¢ãŒã³ãºãéææ§æ³ããéããããšãã蚌æ ãæç€ºããããšããã¿ããã¯ã¯ããã®çš®ã®è¡åã¯å®å šã«äžé©åãã§ãããHHSã¯ã¢ãŒã³ãºã調æ»ããéã« ãæé ãå¿ å®ã« ãèžãã§ãããšè¿°ã¹ãã
ãç§ã«ã¯åœŒãè°äŒã«åãã€ããããã«èŠããããã¯é眪ã§ãããšã³ããŒã¯èšã£ãã